Vaxart
(OTC) VXRT
Vaxart Financials at a Glance
Market Cap
$149.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$255.61M
Net Income (TTM)
$37.10M
EPS (TTM)
$0.15
P/E Ratio
4.14
Dividend
$0.00
Beta (Volatility)
1.70 (High)
Dividend
$0.00
Beta (Volatility)
1.70 (High)
Price
$0.55
Volume
425,562
Open
$0.61
Price
$0.55
Volume
425,562
Open
$0.61
Previous Close
$0.55
Daily Range
$0.55 - $0.63
52-Week Range
$0.26 - $0.84
Estimated Earnings Date
May 7, 2026
Dividend
$0.00
Beta (Volatility)
1.70 (High)
Price
$0.55
Volume
425,562
Open
$0.61
Previous Close
$0.55
Daily Range
$0.55 - $0.63
52-Week Range
$0.26 - $0.84
Estimated Earnings Date
May 7, 2026
VXRT News
Can This 1 Thing Hurt Vaxart?
Is Vaxart the Next Moderna?
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vaxart
Industry
Biotechnology
Sector
Health CareEmployees
74
CEO
Steven Lo
Website
vaxart.comHeadquarters
South San Francisco, CA 94080, US
VXRT Financials
Key Financial Metrics (TTM)
Gross Margin
100.00%
Operating Margin
14.94%
Net Income Margin
14.51%
Return on Equity
61.43%
Return on Capital
18.67%
Return on Assets
20.60%
Earnings Yield
24.15%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$149.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
242.04M
Volume
425.56K
Avg. Volume
393.06K
Financials (TTM)
Gross Profit
$255.61M
Operating Income
$38.18M
EBITDA
$47.30M
Operating Cash Flow
$15.26M
Capital Expenditure
-$463.00K
Free Cash Flow
$14.80M
Cash & ST Invst.
$61.02M
Total Debt
$7.97M
Vaxart Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$39.23M
+87.9%
Gross Profit
$39.23M
+87.9%
Gross Margin
100.00%
N/A
Market Cap
$149.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$2.30M
N/A
Employees
65
N/A
Net Income
$5.18M
+133.2%
EBITDA
$6.84M
+155.8%
Quarterly Fundamentals
Total Cash
$61.02M
+45.5%
Total Debt
$7.97M
-52.6%
Accounts Receivable
$57.57M
+257.1%
Inventory
$0.00
N/A
Long Term Debt
$5.44M
-59.9%
Short Term Debt
$2.53M
-22.3%
Return on Assets
20.60%
N/A
Return on Invested Capital
36.99%
N/A
Free Cash Flow
-$2.50M
+74.3%
Operating Cash Flow
-$2.05M
+78.6%